CorMedix Inc.

NASDAQ: CRMD · Real-Time Price · USD
12.74
0.13 (1.03%)
At close: Aug 15, 2025, 2:34 PM

CorMedix Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
43.47M n/a 65.41K 190.94K
Cost of Revenue
3.19M 205.56K 3.73K 148.94K
Gross Profit
40.28M -205.56K 61.67K 42K
Operating Income
-22.36M -48.96M -30.62M -29.44M
Interest Income
2.58M 2.68M 326.02K 14.4K
Pretax Income
-19.32M -46.34M -30.29M -29.46M
Net Income
-17.93M -46.34M -29.7M -28.21M
Selling & General & Admin
58.7M 35.8M 20.01M 16.35M
Research & Development
3.94M 13.16M 10.68M 13.13M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
62.64M 48.96M 30.69M 29.48M
Interest Expense
36.41K n/a 26.52K 15.94K
Selling & Marketing Expenses
28.74M 18.12M n/a n/a
Cost & Expenses
65.83M 48.96M 30.69M 29.63M
Income Tax Expense
-1.39M n/a -585.62K -1.25M
Shares Outstanding (Basic)
58.87M 50.9M 40.14M 37.61M
Shares Outstanding (Diluted)
58.87M 50.9M 40.27M 37.67M
EPS (Basic)
-0.3 -0.91 -0.74 -0.75
EPS (Diluted)
-0.3 -0.91 -0.74 -0.75
EBITDA
-18.83M -48.89M -30.05M -29.38M
EBIT
-19.29M -46.34M -30.26M -29.44M
Depreciation & Amortization
457.36K 70.75K 209.04K 177.02K